A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge
- PMID: 33966476
- PMCID: PMC8114315
- DOI: 10.1177/23247096211013193
A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge
Abstract
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria, hematuria, azotemia, and hypertension are characteristic features of this condition. Crescentic glomerulonephritis is further classified according to the staining pattern on immunofluorescence. In rare instances, a mixed pattern of injury is encountered as in the case of double antibody-positive rapidly progressive glomerulonephritis (RPGN). This case illustrates the challenge in treatment of double antibody-positive RPGN in an elderly female with no previous renal disease. The patient was found to be positive for anti-GBM antibody and MPO-ANCA. Treatment was initially targeted against MPO-ANCA as the biopsy was most consistent with this process; however, the patient failed to respond to treatment and was subsequently transitioned to oral cyclophosphamide directed against anti-GBM disease. In cases of doubly antibody-positive RPGN with anti-GBM disease and ANCA-associated vasculitis, initial treatment should focus on inducing remission of anti-GBM disease as double antibody-positive disease often presents with the aggressive morbidity and mortality seen in anti-GBM disease, and the chronic risk of relapse seen in ANCA-mediated vasculitis.
Keywords: ANCA-associated vasculitis; anti-glomerular basement membrane disease; crescentic glomerulonephritis.
Conflict of interest statement
Figures


Similar articles
-
MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.Ren Fail. 2011;33(6):626-31. doi: 10.3109/0886022X.2011.581401. Epub 2011 May 20. Ren Fail. 2011. PMID: 21599422
-
Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.Clin Exp Nephrol. 2011 Apr;15(2):226-34. doi: 10.1007/s10157-010-0390-0. Epub 2011 Jan 20. Clin Exp Nephrol. 2011. PMID: 21246240
-
Antineutrophil cytoplasmic antibody (ANCA) and rapidly progressive crescentic glomerulonephritis in Thai population.Asian Pac J Allergy Immunol. 1999 Dec;17(4):281-7. Asian Pac J Allergy Immunol. 1999. PMID: 10698468
-
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.Am J Kidney Dis. 2005 Aug;46(2):253-62. doi: 10.1053/j.ajkd.2005.05.003. Am J Kidney Dis. 2005. PMID: 16112043 Review.
-
[Rapid progressive glomerulonephritis].Internist (Berl). 2019 May;60(5):478-484. doi: 10.1007/s00108-019-0575-x. Internist (Berl). 2019. PMID: 30868251 Review. German.
Cited by
-
Management of Double-Seropositive Anti-Glomerular Basement Membrane and Anti-Neutrophil Cytoplasmic Antibodies with 100% Crescentic Glomerulonephritis and Nephrotic Range Proteinuria in a Young Female.Biomedicines. 2024 Apr 19;12(4):906. doi: 10.3390/biomedicines12040906. Biomedicines. 2024. PMID: 38672260 Free PMC article.
-
A Rare Case of ANCA-negative Rapidly Progressive Glomerulonephritis: A Case Report.J Community Hosp Intern Med Perspect. 2024 Jul 2;14(4):75-78. doi: 10.55729/2000-9666.1371. eCollection 2024. J Community Hosp Intern Med Perspect. 2024. PMID: 39391123 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous